Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scanary is a healthcare technology company specializing in AI-driven dermatology and skin cancer screening. The company's primary product is a mobile application that utilizes advanced computer vision and deep learning algorithms to analyze photos of skin lesions, providing users with instant risk assessments for conditions like melanoma. By enabling early detection through accessible smartphone technology, Scanary aims to bridge the gap between patients and dermatologists, potentially improving outcomes for skin cancer patients. The platform is designed to assist in the monitoring of moles and other skin changes over time. It serves as a digital health tool for proactive skin monitoring and education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scanary.